¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ : ¹Ý·Áµ¿¹°º°, Á¦Çüº°, Åõ¿© °æ·Îº°, À¯Çüº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Pet Dewormers Market Size, Share & Trends Analysis Report By Pet (Dogs, Cats), By Dosage Form (Liquids, Tablets), By Route Of Administration, By Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå
:
1654319
¸®¼Ä¡»ç
:
Grand View Research, Inc.
¹ßÇàÀÏ
:
2025³â 01¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 150 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ
Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼¿¡ µû¸£¸é ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 39¾ï 8,800¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç 2025³âºÎÅÍ 2030³â±îÁö 8.61%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ½ÃÀå ¼ºÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ±â»ýÃæ¿¡ ´ëÇÑ ÀÎ½Ä ¹× ±³À° ³ë·Â, ¹Ý·Áµ¿¹° ±â»ýÃæ °ü¸®ÀÇ Á߿伺 Áõ°¡, »õ·Î¿î ±â»ýÃæÀÇ ÃâÇö, R&D Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ¿¬±¸¿¡ µû¸£¸é ¹Ì±¹, EU, ¿µ±¹¿¡¼ ¹Ý·Áµ¿¹°ÀÇ ±â»ýÃæ À¯º´·üÀÌ ³ô°í ¶óÀÓº´, ½ÉÀå»ç»óÃæ°ú °°Àº ±â»ýÃæ°ú ¸Å°³Ã¼ ¸Å°³ Áúº´(VBD)ÀÌ »õ·Î¿î Áö¿ªÀ¸·Î È®»êµÇ°í ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. Áøµå±â, º·è, ¸®½´¸¶´Ï¾Æ °°Àº ±â»ýÃæÀº »ç¶÷¿¡°Ô Áúº´À» Àü¿°½Ãų ¼ö ÀÖÀ¸¸ç, ÀÌ´Â ¹Ý·Áµ¿¹°ÀÇ °¨¿°·ü°ú °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¸®½´¸¶´Ï¾ÆÁõÀº ºê¶óÁú¿¡¼ Ä¡»çÀ²ÀÌ ¸Å¿ì ³ôÀ¸¸ç º·è °¨¿°Àº °³ÀÔ ¾øÀ̵µ ¼ö°³¿ù µ¿¾È Áö¼ÓµÉ ¼ö ÀÖ½À´Ï´Ù.
¶ÇÇÑ Àü ¼¼°èÀûÀ¸·Î ¹Ý·Áµ¿¹° ¼ÒÀ¯ÁÖµéÀÇ ³·Àº ÁؼöÀ²Àº ±¸Ãæ Á¦Ç°ÀÇ ¹Ì°³Ã´ ½ÃÀå ÀáÀç·ÂÀ» º¸¿©ÁÝ´Ï´Ù. ³×´ú¶õµå, ¿µ±¹, Æ÷¸£Åõ°¥¿¡¼´Â ¹Ý·Áµ¿¹°ÀÇ 5-16%¸¸ÀÌ ±ÇÀåµÇ´Â ±¸Ãæ ¹æ¹ýÀ» µû¸£°í ÀÖ¾î ±³À°°ú Á¦Ç° µµÀÔÀ» È®´ëÇØ¾ß ÇÒ Çʿ伺ÀÌ Á¦±âµÇ°í ÀÖ½À´Ï´Ù. Áö¿ª ¼öÀÇ»çȸ(CAPC, ESCCAP, TROCCAP)´Â °¡À̵å¶óÀÎÀ» ¼³Á¤Çϰí È¿°úÀûÀÎ ±â»ýÃæ °ü¸®¸¦ Àå·ÁÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.
±â»ýÃæ ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÀÌ¿¡ µû¸¥ ¹Ý·Áµ¿¹°ÀÇ ±â»ýÃæ °ü¸®ÀÇ Á߿伺 Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ºü¸£°Ô °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º·è, Áøµå±â, Áøµå±â, ¹ú·¹¿Í °°Àº ±â»ýÃæÀº ¹Ý·Áµ¿¹°¿¡°Ô Æò»ý À§ÇèÀ» ÃÊ·¡ÇÏ¿© ºÒÆíÇÔ, Áúº´À» À¯¹ßÇÏ°í Æ¯È÷ ¾î¸°ÀÌ, ³ëÀÎ ¶Ç´Â ¸é¿ª·ÂÀÌ ¾àÇÑ »ç¶÷°ú °°Àº Ãë¾àÇÑ »ç¶÷µé¿¡°Ô Àμö°øÅëÀü¿°º´À» Àü¿°½Ãų ¼ö ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° Àα¸ Áõ°¡, ±âÈÄ º¯È, À̵¿¼º Áõ°¡¿Í °°Àº Àü ¼¼°èÀûÀÎ ¿äÀÎÀ¸·Î ÀÎÇØ ±â»ýÃæÀÇ À¯º´·ü°ú Áö¸®Àû È®»êÀÌ È®´ëµÇ°í ÀÖ¾î È¿°úÀûÀÎ °ü¸® ´ëÃ¥ÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, Animal Friend LifeÀÇ 2024³â 5¿ù ±â»ç¿¡ µû¸£¸é È£ÁÖÀÇ ±â»ó Á¶°ÇÀ¸·Î ÀÎÇØ »ç¶÷»Ó¸¸ ¾Æ´Ï¶ó °³¿¡°Ôµµ È¸Ãæ °¨¿°ÀÌ Áõ°¡Çϰí ÀÖ´Ù°í ÇÕ´Ï´Ù. Åå¼ÒÄ«¶ó È¸Ãæ°ú °°Àº ±â»ýÃæÀÇ È®»êÀº ¾à 200¸¸ ¸íÀÇ È£ÁÖÀο¡°Ô ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ¾à 25%¿¡ ´ÞÇÏ´Â ¸¹Àº ¹Ý·Áµ¿¹° º¸È£ÀÚ°¡ ¹Ý·Á°ß¿¡°Ô ±¸ÃæÁ¦¸¦ Åõ¿©ÇÏÁö ¾Ê¾Ò´Ù°í ÀÎÁ¤Çß½À´Ï´Ù. Àü¹®°¡µéÀº ÀÌ·¯ÇÑ »óȲÀ» Á¶±â¿¡ ÇØ°áÇϱâ À§ÇØ Á¤±âÀûÀÎ ±¸Ãæ, ¹Ý·Áµ¿¹° ¹è¼³¹°ÀÇ ½Å¼ÓÇÑ Ã³¸®, ³¯°í±â ½Ä´Ü ÇÇÇϱ⠵îÀ» ±ÇÀåÇϰí ÀÖ½À´Ï´Ù.
¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀå ÇÏÀ̶óÀÌÆ®
- °³ ºÎ¹®Àº 2024³â¿¡ 37.84 %ÀÇ »ó´çÇÑ Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç °í¾çÀÌ ºÎ¹®Àº 2025-2030³â ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGRÀ» ±â·ÏÇß½À´Ï´Ù. ÀÌ´Â ¹Ý·Áµ¿¹°ÀÇ ¼ÒÀ¯À²ÀÌ ³ô°í ½ÉÀå»ç»óÃæÀ̳ª Áøµå±â¿Í °°Àº ±â»ýÃæ¿¡ ´ëÇÑ °¨¼ö¼ºÀÌ ³ô¾Æ Á¤±âÀûÀÎ ¿¹¹æ °ü¸®°¡ ÇÊ¿äÇϱ⠶§¹®ÀÏ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ¿¬±¸¿¡ µû¸£¸é º¸È£¼Ò ¹Ý·Á°ßÀÇ 21%°¡ Áö¾Æ¸£µð¾Æ ¾ç¼º ¹ÝÀÀÀ» º¸¿© ±¸Ãæ Á¦Ç°ÀÇ Çʿ伺ÀÌ °Á¶µÇ°í ÀÖ½À´Ï´Ù.
- Åõ¿© °æ·Î¿¡ µû¶ó °æ±¸¿ë ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È 9.61%ÀÇ °¡Àå ºü¸¥ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °æ±¸¿ë ¹Ý·Áµ¿¹° ±¸ÃæÁ¦´Â Åõ¿©ÀÇ ¿ëÀ̼º, ³ôÀº È¿´É, È¸Ãæ ¹× ÃÌÃæÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ±â»ýÃæÀ» Ç¥ÀûÀ¸·Î ÇÏ´Â ´É·ÂÀ¸·Î ÀÎÇØ ½ÃÀåÀ» Áö¹èÇϰí ÀÖ½À´Ï´Ù. Æí¸®ÇÏ°í ¹Ý·Áµ¿¹° Ä£ÈÀûÀÎ Á¦ÇüÀº ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀÇ ¼øÀÀµµ¸¦ ³ô¿© ´Ù¾çÇÑ ¼ÒºñÀÚ ´ÏÁ ÃæÁ·½ÃÅ´À¸·Î½á ½ÃÀå ¼ºÀåÀ» Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
- À¯Çü¿¡ µû¶ó ó¹æ¾à ºÎ¹®Àº 2024³â¿¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGRÀ» ±â·ÏÇß½À´Ï´Ù. À̴ ƯÁ¤ ±â»ýÃæ °¨¿°¿¡ ´ëÇÑ Ç¥Àû È¿´ÉÀ¸·Î ´õ ³ôÀº ¾ÈÀü¼º°ú È¿°ú¸¦ º¸ÀåÇϱ⠶§¹®ÀÏ ¼ö ÀÖ½À´Ï´Ù. ¼öÀÇ»çµéÀÇ ÁöÁö¿Í ¸ÂÃãÇü ¹Ý·Áµ¿¹° Ä¡·á °èȹÀº ó¹æ ±â¹Ý ±¸ÃæÁ¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
- À¯Åë ä³Îº°·Î º¸¸é, µ¿¹° º´¿ø ¹× Ŭ¸®´Ð ºÎ¹®Àº Àü¹®°¡ »ó´ã, Á¤È®ÇÑ Áø´Ü, ¸ÂÃãÇü ±¸Ãæ Ä¡·á¸¦ Á¦°øÇÏ´Â ¿ªÇÒ·Î ÀÎÇØ 2024³â ½ÃÀåÀ» Áö¹èÇß½À´Ï´Ù. ¶ÇÇÑ ¼÷·ÃµÈ Àü¹®°¡ÀÇ Á¸Àç´Â ±¸ÃæÁ¦ÀÇ ÀûÀýÇÑ »ç¿ë°ú ¸ð´ÏÅ͸µÀ» º¸ÀåÇÏ¿© ´õ ³ôÀº äÅ÷ü·Î À̾îÁý´Ï´Ù.
- ºÏ¹ÌÀÇ ½ÃÀåÀº 2024³â Àü ¼¼°è¿¡¼ 35.36%·Î °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ì¼¼´Â ³ôÀº ¹Ý·Áµ¿¹° ¼ÒÀ¯À², ¹Ý·Áµ¿¹° °Ç°¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¿¹¹æ Ä¡·á¿¡ ´ëÇÑ °·ÂÇÑ ¼ö¿ä¿¡ ±âÀÎÇÑ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¶ÇÇÑ, ¼±ÁøÈµÈ ¼öÀÇÇÐ ÀÇ·á ÀÎÇÁ¶ó¿Í Àß Á¤¸³µÈ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©µµ ÀÌ Áö¿ªÀÇ ½ÃÀå ¸®´õ½Ê¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀåÀÇ º¯µ¿ µ¿Çâ°ú ¹üÀ§
- ½ÃÀå °èÅëÀÇ Àü¸Á
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- ½ÃÀå ±âȸ ºÐ¼®
- ½ÃÀå °úÁ¦ ºÐ¼®
- ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀå ºÐ¼® Åø
- »ê¾÷ ºÐ¼® - Porter's Five Forces ºÐ¼®
- PESTEL ºÐ¼®
- ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
- ÁÖ¿ä±¹°ú ÁÖ¿äÁ¾¿¡ ÀÇÇÑ µ¿¹°ÀÇ ÃßÁ¤ °³Ã¼¼ö(2018-2023³â)
- °¡°Ý ºÐ¼®
- COVID-19ÀÇ ¿µÇ⠺м®
Á¦4Àå ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀå : ¹Ý·Áµ¿¹°º°, ÃßÁ¤ ¹× µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀåÀÇ ¹Ý·Áµ¿¹° º¯µ¿ ºÐ¼®
- ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, ¹Ý·Áµ¿¹°º°(2018-2030³â)
Á¦5Àå ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀå : Åõ¿© °æ·Îº°, ÃßÁ¤ ¹× µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀåÀÇ Åõ¿© °æ·Î º¯µ¿ ºÐ¼®
- ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, Åõ¿© °æ·Îº°(2018-2030³â)
Á¦6Àå ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀå : Á¦Çüº°, ÃßÁ¤ ¹× µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀåÀÇ Á¦Çü º¯µ¿ ºÐ¼®
- ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, Á¦Çüº°(2018-2030³â)
Á¦7Àå ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀå : À¯Çüº°, ÃßÁ¤ ¹× µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀåÀÇ À¯Çü º¯µ¿ ºÐ¼®
- ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, À¯Çüº°(2018-2030³â)
Á¦8Àå ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀå : À¯Åë ä³Îº°, ÃßÁ¤ ¹× µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀåÀÇ À¯Åë ä³Î º¯µ¿ ºÐ¼®
- ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, À¯Åë ä³Îº°(2018-2030³â)
- µ¿¹°º´¿ø ¹× Ŭ¸®´Ð
- ¼Ò¸ÅÁ¡, ¹Ý·Áµ¿¹°Á¡
- ÀüÀÚ»ó°Å·¡
Á¦9Àå ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀå : ¹Ý·Áµ¿¹°º°, Åõ¿©Çüº°, Åõ¿©°æ·Îº°, À¯Çüº°, À¯Åëä³Î¿¡ ÀÇÇÑ Áö¿ªº°, ÃßÁ¤ ¹× µ¿Ç⠺м®
- Áö¿ª ´ë½Ãº¸µå
- ¹Ý·Áµ¿¹° ±¸ÃæÁ¦ ½ÃÀå Á¡À¯À², Áö¿ªº°(2023³â, 2030³â, 100¸¸ ´Þ·¯)
- Áö¿ª Àü¸Á
- ºÏ¹Ì
- À¯·´
- ½ºÆäÀÎ
- µ¶ÀÏ
- Æ÷¸£Åõ°¥
- ·ç¸¶´Ï¾Æ
- ½½·Î¹ÙŰ¾Æ
- üÄÚ¾î
- Çë°¡¸®
- Æú¶õµå
- ÀÌÅ»¸®¾Æ
- ¾ÆÀÏ·£µå
- ¿µ±¹
- ÇÁ¶û½º
- µ§¸¶Å©
- ½º¿þµ§
- ³ë¸£¿þÀÌ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ÀϺ»
- Áß±¹
- Àεµ
- È£ÁÖ
- Çѱ¹
- ű¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ³²¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- Äí¿þÀÌÆ®
Á¦10Àå °æÀï ±¸µµ
- ½ÃÀå ÁøÃâ±â¾÷ÀÇ ºÐ·ù
- ½ÃÀå ÁøÃâ±â¾÷ÀÇ °³¿ä
- ½ÃÀå Æ÷Áö¼Å´× ºÐ¼®(2024³â, È÷Æ® ¸Ê ºÐ¼®)
- Àü·« ¸ÅÇÎ
- ÇÕº´°ú Àμö
- ·±Ä¡
- ÆÄÆ®³Ê½Ê°ú Çù¾÷
- È®´ë
- ±âŸ
- ±â¾÷ ÇÁ·ÎÆÄÀÏ
- Zoetis
- Boehringer Ingelheim
- Merck &Co. Inc.
- Dechra Pharmaceuticals Plc.
- Elanco Animal Health
- Ceva Sante Animale
- Virbac
- Vetoquinol
- Hester Biosciences Limited
- Intas Pharmaceuticals Ltd.
- ±âŸ ½ÃÀå ÁøÃâ±â¾÷ À϶÷
Á¦11Àå ÁÖ¿ä Æ÷ÀÎÆ®
HBR
¿µ¹® ¸ñÂ÷
Pet Dewormers Market Growth & Trends:
The global pet dewormers market size is expected to reach USD 3.98 billion by 2030, registering a CAGR of 8.61% from 2025 to 2030, according to a new report by Grand View Research, Inc. Some key factors driving the market growth are awareness and education efforts regarding parasitic worms, the growing importance of parasite control in pets, the emergence of new parasitic worms, and growing R&D initiatives. Studies show a high prevalence of parasites in pets across the U.S., EU, and UK, with parasitic worms and vector-borne diseases (VBDs) like Lyme disease and heartworm spreading to new areas. Parasites such as ticks, fleas, and leishmania can transmit diseases to humans, correlating with pet infection rates. For instance, leishmaniosis has significant fatality rates in Brazil, and flea infestations can persist for months without intervention.
Furthermore, low compliance rates among pet owners globally highlight untapped market potential for deworming products. In the Netherlands, UK, and Portugal, only 5-16% of pets follow recommended deworming practices, signaling a need for increased education and product adoption. Regional veterinary councils (CAPC, ESCCAP, TROCCAP) play a crucial role in setting guidelines and promoting effective parasite control.
The growing prevalence of parasitic diseases and, subsequently, the rise in the importance of parasitic control in pets is expected to drive market growth rapidly. Parasites such as fleas, ticks, mites, and worms pose lifelong risks to pets, causing discomfort, disease, and potential transmission of zoonotic illnesses to humans, especially vulnerable populations like children, the elderly, or immunocompromised individuals. Global factors like rising pet populations, climate change, and increased mobility are expanding parasite prevalence and geographic spread, necessitating effective control measures. For instance, according to the May 2024 article by Animal Friend Life reported that weather conditions in Australia have led to a rise in roundworm infections among dogs as well as humans. Spread of parasitic worms like Toxocara roundworms has affected around two million Australians. Many pet owners, i.e., around 25%, have admitted to never deworming their dogs. Experts have recommended regular deworming, prompt disposal of pet feces, and avoiding raw meat diets for pets to tackle this situation in its early stages.
Pet Dewormers Market Report Highlights:
- The dogs segment held a significant share of 37.84% in 2024, and the cats segment had the fastest CAGR over the forecast period of 2025-2030. This can be attributed to higher ownership rates and susceptibility to parasites like heartworms and ticks requiring regular preventive care. For instance, U.S. studies show that 21% of shelter dogs test positive for Giardia, highlighting the critical need for deworming products.
- Based on the route of administration, the oral segment is anticipated to grow at the fastest CAGR of 9.61% over the forecast period. Oral pet dewormers dominate the market due to their ease of administration, high efficacy, and ability to target a wide range of parasites, including roundworms and tapeworms. Their convenience and pet-friendly formulations drive compliance among pet owners, significantly boosting market growth by meeting diverse consumer needs.
- Based on type, the prescription segment held the largest share in 2024 and the fastest CAGR over the forecast period. This can be attributed to their targeted efficacy against specific parasitic infections, ensuring higher safety and effectiveness. Veterinarians' endorsement and customized pet treatment plans further drive the demand for prescription-based dewormers.
- By distribution channel, the Veterinary Hospitals/Clinics segment dominated the market in 2024 owing to their role in providing expert consultations, accurate diagnoses, and tailored deworming treatments. In addition, the presence of trained professionals ensures proper usage and monitoring of dewormers, leading to higher adoption rates.
- North America market held the largest share of 35.36% globally in 2024. The dominance can be attributed to high pet ownership rates, increased awareness of pet health, and a strong demand for preventative care. In addition, advanced veterinary healthcare infrastructure and a well-established regulatory framework further contribute to the region's market leadership.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources
- 1.3.4. Primary Research
- 1.4. Information/Data Analysis
- 1.5. Market Formulation & Visualization
- 1.6. Data Validation & Publishing
- 1.7. Model Details
- 1.7.1. Commodity flow analysis
- 1.7.2. Global Market: CAGR Calculation
- 1.8. List of Secondary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Pet Dewormers Market Variable Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market
- 3.1.2. Ancillary Market
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Awareness and Education Efforts Regarding Parasitic Worms
- 3.2.1.2. Growing Importance of Parasite Control in Pets
- 3.2.1.3. Increasing Expert Scrutiny
- 3.2.1.4. Increasing of Zoonotic Diseases Transfer from Pets
- 3.2.1.5. Evolving Regulations
- 3.2.1.6. Emergence of New Parasitic Worms
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Development of Drug Resistance
- 3.2.2.2. Emergence of Unverified Treatments
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.3. Pet Dewormers Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitution
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal Landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental Landscape
- 3.3.3. Regulatory Framework
- 3.3.4. Estimated Animal Population, by Key Countries and Key Species, 2018-2023
- 3.3.5. Pricing Analysis
- 3.3.6. COVID-19 Impact Analysis
Chapter 4. Pet Dewormers Market: Pet Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Pet Dewormers Market Pet Movement Analysis
- 4.3. Pet Dewormers Market Size & Trend Analysis, By Pet, 2018 - 2030 (USD Million)
- 4.3.1. Dogs
- 4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.3.2. Cats
- 4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.3.3. Horses
- 4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.3.4. Other Pets
- 4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Pet Dewormers Market: Route of Administration Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Pet Dewormers Market Route of Administration Movement Analysis
- 5.3. Pet Dewormers Market Size & Trend Analysis, By Route of Administration, 2018 - 2030 (USD Million)
- 5.3.1. Oral
- 5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.3.2. Injectable
- 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.3.3. Topical
- 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Pet Dewormers Market: Dosage Form Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Pet Dewormers Market Dosage Form Movement Analysis
- 6.3. Pet Dewormers Market Size & Trend Analysis, By Dosage Form, 2018 - 2030 (USD Million)
- 6.3.1. Liquids
- 6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.2. Tablets
- 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Pet Dewormers Market: Type Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Pet Dewormers Market Type Movement Analysis
- 7.3. Pet Dewormers Market Size & Trend Analysis, By Type, 2018 - 2030 (USD Million)
- 7.3.1. OTC
- 7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.2. Prescription
- 7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Pet Dewormers Market: Distribution Channel Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. Pet Dewormers Market Distribution Channel Movement Analysis
- 8.3. Pet Dewormers Market Size & Trend Analysis, By Distribution Channel, 2018 - 2030 (USD Million)
- 8.3.1. Veterinary Hospitals/Clinics
- 8.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 8.3.2. Retail/Pet Stores
- 8.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 8.3.3. E-commerce
- 8.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Pet Dewormers Market: Regional Estimates & Trend Analysis, by pet, route of administration, dosage form, type, & distribution channel
- 9.1. Regional Dashboard
- 9.2. Pet Dewormers Market Share, By Region, 2023 & 2030, USD Million
- 9.3. Regional Outlook
- 9.4. North America
- 9.4.1. North America Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.2. U.S.
- 9.4.2.1. Key Country Dynamics
- 9.4.2.2. U.S. Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.3. Canada
- 9.4.3.1. Key Country Dynamics
- 9.4.3.2. Canada Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.4. Mexico
- 9.4.4.1. Key Country Dynamics
- 9.4.4.2. Mexico Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5. Europe
- 9.5.1. Europe Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.2. Spain
- 9.5.2.1. Key Country Dynamics
- 9.5.2.2. Spain Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.3. Germany
- 9.5.3.1. Key Country Dynamics
- 9.5.3.2. Germany Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.4. Portugal
- 9.5.4.1. Key Country Dynamics
- 9.5.4.2. Portugal Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.5. Romania
- 9.5.5.1. Key Country Dynamics
- 9.5.5.2. Romania Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.6. Slovakia
- 9.5.6.1. Key Country Dynamics
- 9.5.6.2. Slovakia Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.7. Czech
- 9.5.7.1. Key Country Dynamics
- 9.5.7.2. Czech Europe Dog Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.8. Hungary
- 9.5.8.1. Key Country Dynamics
- 9.5.8.2. Hungary Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.9. Poland
- 9.5.9.1. Key Country Dynamics
- 9.5.9.2. Poland Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.10. Italy
- 9.5.10.1. Key Country Dynamics
- 9.5.10.2. Italy Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.11. Ireland
- 9.5.11.1. Key Country Dynamics
- 9.5.11.2. Ireland Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.12. UK
- 9.5.12.1. Key Country Dynamics
- 9.5.12.2. UK Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.13. France
- 9.5.13.1. Key Country Dynamics
- 9.5.13.2. France Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.14. Denmark
- 9.5.14.1. Key Country Dynamics
- 9.5.14.2. Denmark Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.15. Sweden
- 9.5.15.1. Key Country Dynamics
- 9.5.15.2. Sweden Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.16. Norway
- 9.5.16.1. Key Country Dynamics
- 9.5.16.2. Norway Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6. Asia Pacific
- 9.6.1. Asia Pacific Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.2. Japan
- 9.6.2.1. Key Country Dynamics
- 9.6.2.2. Japan Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.3. China
- 9.6.3.1. Key Country Dynamics
- 9.6.3.2. China Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.4. India
- 9.6.4.1. Key Country Dynamics
- 9.6.4.2. India Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.5. Australia
- 9.6.5.1. Key Country Dynamics
- 9.6.5.2. Australia Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.6. South Korea
- 9.6.6.1. Key Country Dynamics
- 9.6.6.2. South Korea Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.7. Thailand
- 9.6.7.1. Key Country Dynamics
- 9.6.7.2. Thailand Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.7. Latin America
- 9.7.1. Latin America Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.7.2. Brazil
- 9.7.2.1. Key Country Dynamics
- 9.7.2.2. Brazil Pet Dewormers Market Estimates And Forecasts, 2018 - 2030
- 9.7.3. Argentina
- 9.7.3.1. Key Country Dynamics
- 9.7.3.2. Argentina Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8. Middle East & Africa
- 9.8.1. Middle East & Africa Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.2. South Africa
- 9.8.2.1. Key Country Dynamics
- 9.8.2.2. South Africa Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.3. Saudi Arabia
- 9.8.3.1. Key Country Dynamics
- 9.8.3.2. Saudi Arabia Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.4. UAE
- 9.8.4.1. Key Country Dynamics
- 9.8.4.2. UAE Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.5. Kuwait
- 9.8.5.1. Key Country Dynamics
- 9.8.5.2. Kuwait Pet Dewormers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
- 10.1. Market Participant Categorization
- 10.2. Participants Overview
- 10.3. Financial Performance
- 10.4. Product Benchmarking
- 10.5. Market Position Analysis, 2024 (Heat Map Analysis)
- 10.6. Strategy Mapping
- 10.6.1. MERGERS AND ACQUISITIONS
- 10.6.2. LAUNCH
- 10.6.3. PARTNERSHIPS & COLLABORATIONS
- 10.6.4. EXPANSION
- 10.6.5. OTHERS
- 10.7. Company Profiles
- 10.7.1. Zoetis
- 10.7.1.1. Participant's overview
- 10.7.1.2. Financial performance
- 10.7.1.3. Product Benchmarking
- 10.7.1.4. Strategic initiatives
- 10.7.2. Boehringer Ingelheim
- 10.7.2.1. Participant's overview
- 10.7.2.2. Financial performance
- 10.7.2.3. Product Benchmarking
- 10.7.2.4. Strategic initiatives
- 10.7.3. Merck & Co. Inc.
- 10.7.3.1. Participant's overview
- 10.7.3.2. Financial performance
- 10.7.3.3. Product Benchmarking
- 10.7.3.4. Strategic initiatives
- 10.7.4. Dechra Pharmaceuticals Plc.
- 10.7.4.1. Participant's overview
- 10.7.4.2. Financial performance
- 10.7.4.3. Product Benchmarking
- 10.7.4.4. Strategic initiatives
- 10.7.5. Elanco Animal Health
- 10.7.5.1. Participant's overview
- 10.7.5.2. Financial performance
- 10.7.5.3. Product Benchmarking
- 10.7.5.4. Strategic initiatives
- 10.7.6. Ceva Sante Animale
- 10.7.6.1. Participant's overview
- 10.7.6.2. Financial performance
- 10.7.6.3. Product Benchmarking
- 10.7.6.4. Strategic initiatives
- 10.7.7. Virbac
- 10.7.7.1. Participant's overview
- 10.7.7.2. Financial performance
- 10.7.7.3. Product Benchmarking
- 10.7.7.4. Strategic initiatives
- 10.7.8. Vetoquinol
- 10.7.8.1. Participant's overview
- 10.7.8.2. Financial performance
- 10.7.8.3. Product Benchmarking
- 10.7.8.4. Strategic initiatives
- 10.7.9. Hester Biosciences Limited
- 10.7.9.1. Participant's overview
- 10.7.9.2. Financial performance
- 10.7.9.3. Product Benchmarking
- 10.7.9.4. Strategic initiatives
- 10.7.10. Intas Pharmaceuticals Ltd.
- 10.7.10.1. Participant's overview
- 10.7.10.2. Financial performance
- 10.7.10.3. Product Benchmarking
- 10.7.10.4. Strategic initiatives
- 10.8. List of Other Market Players
Chapter 11. Key Takeaways
°ü·ÃÀÚ·á